Mastocytosis is an uncommon abnormal accumulation of mast cells in the skin and sometimes in various other parts of the body.
Mastocytosis is rare. It differs from typical allergic reactions because it is chronic rather than episodic. Mastocytosis develops when mast cells increase in number and accumulate in tissues over a period of years. Mast cells are part of the immune system and are normally present in many body tissues, particularly the skin, lungs, and lining of the intestines. Mast cells produce histamine, a substance involved in allergic reactions and in the production of stomach acid. Because the number of mast cells increases, levels of histamine increase. Some people have a genetic mutation that causes mastocytosis. What causes the disorder in others is sometimes unclear.
Mastocytosis may affect primarily the skin (called cutaneous mastocytosis) or other parts of the body (called systemic mastocytosis).
A single mastocytoma does not cause symptoms.
Spots and bumps may itch, particularly if they are rubbed or scratched. Itching may be worsened by changes in temperature, contact with clothing or other materials, or use of some drugs, including nonsteroidal anti-inflammatory drugs (NSAIDs). Consuming hot beverages, spicy foods, or alcohol or exercising may also make itching worse. Rubbing or scratching the spots may result in hives and make the skin turn red.
Flushing is common. Peptic ulcers may develop because too much histamine is produced, stimulating secretion of excess stomach acid. Ulcers can cause stomach pain. Nausea, vomiting, and chronic diarrhea may also occur. The abdomen may enlarge if the liver and spleen malfunction, causing fluid to accumulate within the abdomen. If bone marrow is affected, bone pain can result.
Widespread reactions may occur. With systemic mastocytosis, the widespread reactions tend to be severe. They include anaphylactic and anaphylactoid reactions (see Sidebar 2: Anaphylactoid Versus Anaphylactic), which cause fainting and a life-threatening drop in blood pressure (shock). Anaphylactoid reactions resemble anaphylactic reactions, but no allergen triggers them.
Systemic mastocytosis may affect bone marrow, and up to 30% of adults with systemic mastocytosis develop cancers, particularly myelocytic leukemias. In these people, life expectancy may be shortened.
Doctors suspect the diagnosis based on symptoms, particularly spots that, when scratched, result in hives and redness. A biopsy can confirm the diagnosis. Usually, a sample of skin tissue is removed and examined under a microscope for mast cells. Sometimes a sample is taken from the bone marrow.
Blood tests to measure levels of chemical substances related to mast cells are sometimes done. High levels support the diagnosis of systemic mastocytosis.
A mastocytoma usually disappears spontaneously. Itching may be treated with antihistamines. For children, no other treatment is needed. If adults have itching and rashes, ultraviolet light and corticosteroid creams may be applied to the skin.
Systemic mastocytosis cannot be cured, but symptoms can be controlled with antihistamines and histamine-2 (H2) blockers, which reduce acid production in the stomach (see Table: Drugs Used to Treat Peptic Disorders). Cromolyn, given by mouth, can relieve digestive problems and bone pain. Aspirin can relieve flushing but may make other symptoms worse. Children are not given aspirin because Reye syndrome is a risk.
If systemic mastocytosis is aggressive, interferon-alpha, injected under the skin once a week, may reduce the disorder's effects on bone marrow. Corticosteroids (such as prednisone), taken by mouth, may also be used but only for a short time. When taken by mouth for more than 3 to 4 weeks, they can have many, sometimes serious side effects.
If many mast cells accumulate in the spleen, the spleen may be removed. If leukemia develops, chemotherapy drugs (such as daunomycin, etoposide, and mercaptopurine) may help.
A self-injecting syringe of epinephrine should always be carried for prompt emergency treatment of anaphylactic or anaphylactoid reactions.
Last full review/revision May 2014 by Peter J. Delves, PhD